244 related articles for article (PubMed ID: 19052923)
1. Clinical and laboratory features of the catastrophic antiphospholipid syndrome.
Stojanovich L; Marisavljevic D; Rovensky J; Djokovich A; Kozáková D; Milinic N
Clin Rev Allergy Immunol; 2009 Jun; 36(2-3):74-9. PubMed ID: 19052923
[TBL] [Abstract][Full Text] [Related]
2. The catastrophic antiphospholipid syndrome in Serbia: diagnostic and management problems.
Stojanovich L
Clin Rev Allergy Immunol; 2009 Jun; 36(2-3):98-103. PubMed ID: 19048415
[TBL] [Abstract][Full Text] [Related]
3. [Case series and clinical analysis of 14 cases of catastrophic antiphospholipid syndrome].
Gu JY; Lu C; Shi H; Yang CD
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1033-1038. PubMed ID: 30562777
[TBL] [Abstract][Full Text] [Related]
4. Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry.
Rodríguez-Pintó I; Moitinho M; Santacreu I; Shoenfeld Y; Erkan D; Espinosa G; Cervera R;
Autoimmun Rev; 2016 Dec; 15(12):1120-1124. PubMed ID: 27639837
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody explosion in antiphospholipid syndrome.
Shoenfeld Y; Twig G; Katz U; Sherer Y
J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
[TBL] [Abstract][Full Text] [Related]
6. Catastrophic antiphospholipid (Asherson's) syndrome and genetic thrombophilic disorders in obstetrics.
Makatsariya A; Asherson RA; Bitsadze V; Baimuradova S; Akinshina S
Autoimmun Rev; 2006 Dec; 6(2):89-93. PubMed ID: 17138250
[TBL] [Abstract][Full Text] [Related]
7. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and classification of the antiphospholipid syndrome.
Gómez-Puerta JA; Cervera R
J Autoimmun; 2014; 48-49():20-5. PubMed ID: 24461539
[TBL] [Abstract][Full Text] [Related]
9. The physiopathology of the catastrophic antiphospholipid (Asherson's) syndrome: compelling evidence.
Ortega-Hernandez OD; Agmon-Levin N; Blank M; Asherson RA; Shoenfeld Y
J Autoimmun; 2009 Feb; 32(1):1-6. PubMed ID: 19059760
[TBL] [Abstract][Full Text] [Related]
10. CAPS Registry.
Cervera R
Lupus; 2012 Jun; 21(7):755-7. PubMed ID: 22635223
[TBL] [Abstract][Full Text] [Related]
11. An in vitro model to mimic the thrombotic occlusion of small vessels in catastrophic antiphospholipid syndrome (CAPS).
Pontara E; Cheng C; Cattini MG; Bison E; Pelloso M; Denas G; Pengo V
Lupus; 2019 Dec; 28(14):1663-1668. PubMed ID: 31701800
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome.
Galli M
Semin Thromb Hemost; 2008 Jun; 34(4):329-34. PubMed ID: 18814065
[TBL] [Abstract][Full Text] [Related]
13. Anticardiolipin antibody and anti-beta 2 glycoprotein I antibody assays.
Raby A; Moffat K; Crowther M
Methods Mol Biol; 2013; 992():387-405. PubMed ID: 23546732
[TBL] [Abstract][Full Text] [Related]
14. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry".
Cervera R; Bucciarelli S; Plasín MA; Gómez-Puerta JA; Plaza J; Pons-Estel G; Shoenfeld Y; Ingelmo M; Espinos G;
J Autoimmun; 2009; 32(3-4):240-5. PubMed ID: 19324520
[TBL] [Abstract][Full Text] [Related]
15. Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin.
Sheng Y; Hanly JG; Reddel SW; Kouts S; Guerin J; Koike T; Ichikawa K; Sturgess A; Krilis SA
Clin Exp Immunol; 2001 Jun; 124(3):502-8. PubMed ID: 11472415
[TBL] [Abstract][Full Text] [Related]
16. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Alessandri C; Bombardieri M; Di Prospero L; Conigliaro P; Conti F; Labbadia G; Misasi R; Sorice M; Valesini G
Clin Exp Immunol; 2005 Apr; 140(1):173-80. PubMed ID: 15762889
[TBL] [Abstract][Full Text] [Related]
17. [Catastrophic antiphospholipid syndrome].
Costedoat-Chalumeau N; Arnaud L; Saadoun D; Chastre J; Leroux G; Cacoub P; Amoura Z; Piette JC
Rev Med Interne; 2012 Apr; 33(4):194-9. PubMed ID: 22341856
[TBL] [Abstract][Full Text] [Related]
18. Catastrophic antiphospholipid syndrome (CAPS): update from the 'CAPS Registry'.
Cervera R;
Lupus; 2010 Apr; 19(4):412-8. PubMed ID: 20353979
[TBL] [Abstract][Full Text] [Related]
19. Update on the catastrophic antiphospholipid syndrome and the "CAPS Registry".
Cervera R; Espinosa G
Semin Thromb Hemost; 2012 Jun; 38(4):333-8. PubMed ID: 22618528
[TBL] [Abstract][Full Text] [Related]
20. Current clinical and laboratory practice for the investigation of the antiphospholipid syndrome: findings from the 2008 Australasian antiphospholipid antibody survey.
Favaloro EJ; Wong RC
Pathology; 2009; 41(7):666-75. PubMed ID: 20001347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
